TFP
MRK icon

Tilia Fiduciary Partners’s Merck MRK Stock Holding History

Tilia Fiduciary Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,785
Closed -$220K – 120
2025
Q2 		$220K Buy
2,785
+7
+0.3% +$556 0.13% 112
2025
Q1 		$249K Buy
+2,778
New +$259K 0.17% 102
2024
Q4 		– Sell
-1,780
Closed -$202K – 110
2024
Q3 		$202K Buy
+1,780
New +$211K 0.14% 102
2023
Q3 		– Sell
-1,342
Closed -$155K – 326
2023
Q2 		$155K Sell
1,342
-21
-2% -$2.38K 0.14% 103
2023
Q1 		$145K Buy
1,363
+3
+0.2% +$324 0.14% 113
2022
Q4 		$151K Hold
1,360
– – 0.15% 112
2022
Q3 		$124K Buy
1,360
+5
+0.4% +$446 0.13% 119
2022
Q2 		$127K Buy
1,355
+8
+0.6% +$709 0.12% 122
2022
Q1 		$111K Buy
1,347
+95
+8% +$7.49K 0.09% 141
2021
Q4 		$96K Buy
+1,252
New +$99.7K 0.08% 160

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tilia Fiduciary Partners's MRK Position: Q3 2025 in Review

Tilia Fiduciary Partners sold out of Merck (MRK) in Q3 2025, closing a stake of 2,785 shares — an estimated $220K sold.

Tilia Fiduciary Partners first reported a position in MRK in Q4 2021 and held it in 10 quarters. The position peaked at $249K in Q1 2025. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Tilia Fiduciary Partners reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 2,785 Merck shares in Q3 2025, an estimated $220K.
  • Tilia Fiduciary Partners first reported a position in Merck in Q4 2021 and held it in 10 quarters.
  • Tilia Fiduciary Partners's Merck position peaked at $249K in Q1 2025.
  • 3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2025, filed 10 Oct 2025.